The analysis supports making dapagliflozin part of standard inpatient HF pathways rather than postponing it until discharge.
Good morning, ladies and gentlemen, and welcome to the DiaMedica Therapeutics Full Year 2025 Earnings Conference Call. An audio recording of this webcast will be available shortly after the call today ...
Introduction Current international guidelines recommend exercise as a first-line treatment of axial spondyloarthritis (SpA).
RenovoCath- Generates $1.1 Million in 2025 Revenue in First Full Year of Commercialization Phase III TIGeR-PaC Trial on Track for Enrollment Completion by the Middle of 2026, and Final Data Anticipate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results